[Amylasemia in uremics: a complex interpretation]

Riv Eur Sci Med Farmacol. 1994 Jan-Apr;16(1-2):21-5.
[Article in Italian]

Abstract

Plasmatic amylase increases quite often in uremia. Hyperparathyroidism is also present in uremic patients and it is thought to be the main factor of an increased of amylase; its effect is mediated by an increase of cytosolic calcium. The authors measured the plasmatic level of amylase, lipase, calcium phosphates and parathormone before and after administration of Ca-antagonists (Verapamil and Diltiazem). The results did not shown any correlation. Hyperparathyroidism increased the pancreatic secretion but don't influences the amount of enzymes.

Publication types

  • Clinical Trial
  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Amylases / blood*
  • Calcium Channel Blockers / therapeutic use
  • Female
  • Humans
  • Hyperparathyroidism / blood
  • Hyperparathyroidism / enzymology
  • Male
  • Middle Aged
  • Uremia / complications
  • Uremia / drug therapy
  • Uremia / enzymology*

Substances

  • Calcium Channel Blockers
  • Amylases